πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Patent portfolio

United Therapeutics Europe Patents

Full USPTO pharma patent portfolio for United Therapeutics Europe β€” grant dates, expiration, and drug cross-links.

Patents
3,720
Expiring ≀24m
234

Quick answer

United Therapeutics Europe has 3,720 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 234 expire within 24 months β€” use filters for patent-cliff planning.

Page 59 of 78

  1. US 7494980

    Antimicrobial peptide and methods of use thereof

    Expires Mon Feb 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 7491798

    Scytovirins and related conjugates, fusion proteins, nucleic acids, vectors, host cells, compositions, antibodies and methods of using scytovirins

    Expires Mon Feb 12 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 7488710

    SFRP and peptide motifs that interact with SFRP and methods of their use

    Expires Mon Feb 05 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 7488808

    Janus family kinases and identification of immune modulators

    Expires Mon Feb 05 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 7485709

    Identification of a novel BHD gene

    Expires Mon Jan 29 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 7485306

    Lutzomyia longipalpis polypeptides and methods of use

    Expires Mon Jan 29 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 7485440

    Production of attenuated respiratory syncytial virus vaccines involving modification of M2 ORF2

    Expires Mon Jan 29 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 7485457

    Isolated/cloned human NT2 cell lines expressing serotonin and GABA

    Expires Mon Jan 29 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 7485415

    Sequence analysis of the tetravalent rotavirus vaccine

    Expires Mon Jan 29 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 7479280

    Virus-like particles for the induction of autoantibodies

    Expires Mon Jan 15 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 7479269

    Methods for selectively enriching TH1 and TH2 cells

    Expires Mon Jan 15 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 7476535

    TRP2 isoform TRP2-6b containing HLA-A2 restricted epitopes

    Expires Mon Jan 08 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 7470775

    Anti-CD30 stalk and anti-CD30 antibodies suitable for use in immunotoxins

    Expires Mon Dec 25 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 7470506

    Fitness assay and associated methods

    Expires Mon Dec 25 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 7470430

    Modifications of HIV, ENV, GAG, and POL enhance immunogenicity for genetic immunization

    Expires Mon Dec 25 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 7468435

    Polydiazeniumdiolated cyclic polyamines with polyphasic nitric oxide release and related compounds, compositions comprising same and methods of using same

    Expires Mon Dec 18 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 7468352

    Mutated anthrax toxin protective antigen proteins that specifically target cells containing high amounts of cell-surface metalloproteinases or plasminogen activator receptors

    Expires Mon Dec 18 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 7465794

    Polynucleotides encoding recombinant respiratory syncytial viruses expressing immune modulatory molecules

    Expires Mon Dec 11 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 7462356

    Chimeric papillomavirus-like particles

    Expires Mon Dec 04 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 7459536

    HGF-SF monoclonal antibody combinations

    Expires Mon Nov 27 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 7456268

    Materials and methods for inhibiting Wip1

    Expires Mon Nov 20 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 7455994

    Methods for producing Marburg virus proteins

    Expires Mon Nov 20 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 7456222

    Anti tubercular drug: compositions and methods

    Expires Mon Nov 20 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 7452544

    Bacteriocins and novel bacterial strains

    Expires Mon Nov 13 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 7452865

    Antagonistic analogs of GH RH (2003)

    Expires Mon Nov 13 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 7449190

    Assays for assembly of Ebola virus nucleocapsids

    Expires Mon Nov 06 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 7442543

    Mammalian selenoprotein differentially expressed in tumor cells

    Expires Mon Oct 23 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 7439226

    Serine protease inhibitors

    Expires Mon Oct 16 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 7438915

    Immunopotentiating effect of a Fomitella fraxinea-derived lectin on chicken immunity and resistance to coccidiosis

    Expires Mon Oct 16 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 7435801

    Antibodies and other ligands directed against KIR2DL4 receptor for production of interferon gamma

    Expires Mon Oct 09 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 7432349

    Tumor suppressor gene, p28ING5

    Expires Mon Oct 02 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 7431931

    Compositions and method for preventing reactogenicity associated with administration of immunogenic live rotavirus compositions

    Expires Mon Oct 02 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 7432236

    Vasostatin as marrow protectant

    Expires Mon Oct 02 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 7432067

    Methods of detection of MATER protein autoantibodies

    Expires Mon Oct 02 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 7427598

    Post-natal administration of activity-dependent neurotrophic factor-derived polypeptides for enhancing learning and memory

    Expires Mon Sep 18 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 7427590

    Neurothrophic components of the ADNF I complex

    Expires Mon Sep 18 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 7427671

    Compositions of alpha platelet derived growth factor receptor nucleic acid and protein and method of making

    Expires Mon Sep 18 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 7427394

    Biodegradable poly(Ξ²-amino esters) and uses thereof

    Expires Mon Sep 18 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 7425218

    Nitric oxide-releasing medical devices

    Expires Mon Sep 11 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 7425611

    Immunogenic HIV-1 multi-clade, multivalent constructs and methods of their use

    Expires Mon Sep 11 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 7422755

    Antimultiorganism glycoconjugate vaccine

    Expires Mon Sep 04 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 7419957

    Peptides of melanoma antigen and their use in diagnostic, prophylactic and therapeutic methods

    Expires Mon Aug 28 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 7419683

    Method of inhibiting side effects of pharmaceutical compositions containing amphiphilic vehicles or drug carrier molecules

    Expires Mon Aug 28 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 7417070

    Compounds and methods for delivery of prostacyclin analogs

    Expires Mon Aug 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 7417136

    Nucleic acid vaccines for prevention of flavivirus infection

    Expires Mon Aug 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 7416878

    Immunogenic compositions including rough phenotype Brucella host strains and complementation DNA fragments

    Expires Mon Aug 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 7410644

    Recombinant pox virus for immunization against tumor-associated antigens

    Expires Mon Aug 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 7410771

    Reagent and method for detecting a Cryptosporidium parvum sporozoite antigen

    Expires Mon Aug 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does United Therapeutics Europe have?

3,720 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do United Therapeutics Europe patents expire?

234 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources Β· Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates β€” weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.